Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities. | Lancet Neurol | 2022 | 35716694 | PubTator, text mining | PubMed |
| Identification of a Genomic Instability-Related Long Noncoding RNA Prognostic Model in Colorectal Cancer Based on Bioinformatic Analysis. | Dis Markers | 2022 | 35711569 | PubTator, text mining | PubMed |
| A Human MSH6 Germline Variant Associated With Systemic Lupus Erythematosus Induces Lupus-like Disease in Mice. | ACR Open Rheumatol | 2022 | 35708944 | PubTator, text mining | PubMed |
| Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer. | Transl Cancer Res | 2022 | 35706796 | PubTator, text mining | PubMed |
| Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma. | Nat Commun | 2022 | 35705558 | PubTator, text mining | PubMed |
| Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report. | Case Rep Oncol | 2022 | 35702676 | PubTator, text mining | PubMed |
| Genomic characterization of lymphomas in patients with inborn errors of immunity. | Blood Adv | 2022 | 35687490 | PubTator, text mining | PubMed |
| Complex mutation profiles in mismatch repair and ribonucleotide reductase mutants reveal novel repair substrate specificity of MutS homolog (MSH) complexes. | Genetics | 2022 | 35686905 | PubTator, text mining | PubMed |
| Insights into Aptamer-Drug Delivery Systems against Prostate Cancer. | Molecules | 2022 | 35684384 | PubTator, text mining | PubMed |
| The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer. | Cancers (Basel) | 2022 | 35681691 | PubTator, text mining | PubMed |
| The current state of molecular profiling in gastrointestinal malignancies. | Biol Direct | 2022 | 35668531 | PubTator, text mining | PubMed |
| The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors. | Front Oncol | 2022 | 35664743 | PubTator, text mining | PubMed |
| Clozapine Long-Term Treatment Might Reduce Epigenetic Age Through Hypomethylation of Longevity Regulatory Pathways Genes. | Front Psychiatry | 2022 | 35664466 | PubTator, text mining | PubMed |
| Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus. | Neoplasia | 2022 | 35661532 | PubTator, text mining | PubMed |
| A DNA Damage Repair Gene Signature Associated With Immunotherapy Response and Clinical Prognosis in Clear Cell Renal Cell Carcinoma. | Front Genet | 2022 | 35656315 | PubTator, text mining | PubMed |
| Novel targets in rectal cancer by considering lncRNA-miRNA-mRNA network in response to Lactobacillus acidophilus consumption: a randomized clinical trial. | Sci Rep | 2022 | 35654932 | PubTator, text mining | PubMed |
| Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System. | Front Genet | 2022 | 35646048 | PubTator, text mining | PubMed |
| Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines. | Int J Oncol | 2022 | 35642662 | PubTator, text mining | PubMed |
| Technical Performance of a 430-Gene Preventative Genomics Assay to Identify Multiple Variant Types Associated with Adult-Onset Monogenic Conditions, Susceptibility Loci, and Pharmacogenetic Insights. | J Pers Med | 2022 | 35629091 | PubTator, text mining | PubMed |
| The Role of DNA Repair in Genomic Instability of Multiple Myeloma. | Int J Mol Sci | 2022 | 35628498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=32